ArticleContemporary clinical trials communications2020

Explorative study of emerging blood biomarkers in progressive multiple sclerosis (EmBioProMS): Design of a prospective observational multicentre pilot study.

Ahmed Abdelhak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.